Chondroprotective effects of high-molecular-weight cross-linked hyaluronic acid in a rabbit knee osteoarthritis model

Osteoarthritis and Cartilage

Volumn 22, Issue 1, 2014, Pages 121-127

  Elmorsy, S ^a   Funakoshi, T ^a   Sasazawa, F ^a   Todoh, M ^b   Tadano, S ^b   Iwasaki, N ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Hyaluronic acid; Molecular weight; Osteoarthritis; Viscoelasticity

Indexed keywords

HYALURONIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTERIOR CRUCIATE LIGAMENT; ARTICLE; ARTICULAR CARTILAGE; CHONDROPROTECTION; CONTROLLED STUDY; CROSS LINKING; FEMALE; FEMUR CONDYLE; HISTOPATHOLOGY; KNEE OSTEOARTHRITIS; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; RABBIT; VISCOELASTICITY;

HYALURONIC ACID; MOLECULAR WEIGHT; OSTEOARTHRITIS; VISCOELASTICITY;

ANIMALS; ANTERIOR CRUCIATE LIGAMENT; ARTHRITIS, EXPERIMENTAL; CARTILAGE, ARTICULAR; DISEASE PROGRESSION; DRUG EVALUATION, PRECLINICAL; ELASTICITY; FEMALE; FEMUR; FRICTION; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; LUBRICATION; MOLECULAR WEIGHT; OSTEOARTHRITIS, KNEE; RABBITS; SYNOVIAL FLUID; VISCOSITY; VISCOSUPPLEMENTATION; VISCOSUPPLEMENTS;

EID: 84891739920     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2013.10.005     Document Type: Article

References (32)

1. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000, 43:1905-1915.
2. Felson D.T., Lawrence R.C., Dieppe P.A., Hirsch R., Helmick C.G., Jordan J.M., et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 2000, 133:635-646.
3. Dixon J.S., Furst D.E. Second-line Agents in the Treatment of Rheumatic Diseases 1992, Dekker, New York.
4. ®) in osteoarthritis of the knee. A randomized, controlled, double-blind, multicenter trial in the Asian population. BMC Musculoskelet Disord 2011, 12:221.
5. Kon E., Filardo G., Drobnic M., Madry H., Jelic M., van Dijk N., et al. Non-surgical management of early knee osteoarthritis. Knee Surg Sports Traumatol Arthrosc 2012, 20:436-449.
6. Jackson R.L., Busch S.J., Cardin A.D. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol Rev 1991, 71:481-539.
7. Smith M.M., Ghosh P. The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int 1987, 7:113-122.
8. Brandt K.D., Smith G.N., Simon L.S. Intraarticular injection of hyaluronan as treatment for knee osteoarthritis: what is the evidence?. Arthritis Rheum 2000, 43:1192-1203.
9. Moreland L.W. Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther 2003, 5:54-67.
10. Conduah A.H., Baker C.L. Managing joint pain in osteoarthritis: safety and efficacy of hylan G-F 20. JPain Res 2009, 2:87-98.
11. Dahl L.B., Dahl I.M., Engstrom-Laurent A., Granath K. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 1985, 44:817-822.
12. Matsuhashi T., Iwasaki N., Nakagawa H., Hato M., Kurogochi M., Majima T., et al. Alteration of N-glycans related to articular cartilage deterioration after anterior cruciate ligament transection in rabbits. Osteoarthritis Cartilage 2008, 16:772-778.
13. Yoshioka M., Shimizu C., Harwood F.L., Coutts R.D., Amiel D. The effects of hyaluronan during the development of osteoarthritis. Osteoarthritis Cartilage 1997, 5:251-260.
14. Kikuchi T., Yamada H., Shimmei M. Effect of high molecular weight hyaluronan on cartilage degeneration in a rabbit model of osteoarthritis. Osteoarthritis Cartilage 1996, 4:99-110.
15. Ferry J.D. Viscoelastic Properties of Polymers 1970, Wiley, New York. 2nd edn.
16. Bird R.B. Dynamics of Polymeric Liquids. Fluid Mechanics 1987, Volume I. Wiley, New York. 2nd edn.
17. Igarashi T., Iwasaki N., Kawamura D., Tsukuda Y., Kasahara Y., Todoh M., et al. Therapeutic effects of intra-articular ultrapurified low endotoxin alginate administration on experimental osteoarthritis in rabbits. Cartilage 2012, 3:70-78.
18. Kawano T., Miura H., Mawatari T., Moro-Oka T., Nakanishi Y., Higaki H., et al. Mechanical effects of the intraarticular administration of high molecular weight hyaluronic acid plus phospholipid on synovial joint lubrication and prevention of articular cartilage degeneration in experimental osteoarthritis. Arthritis Rheum 2003, 48:1923-1929.
19. Yoshimi T., Kikuchi T., Obara T., Yamaguchi T., Sakakibara Y., Itoh H., et al. Effects of high-molecular-weight sodium hyaluronate on experimental osteoarthrosis induced by the resection of rabbit anterior cruciate ligament. Clin Orthop Relat Res 1994, 298:296-304.
20. Shimizu C., Kubo T., Hirasawa Y., Coutts R.D., Amiel D. Histomorphometric and biochemical effect of various hyaluronans on early osteoarthritis. JRheumatol 1998, 25:1813-1819.
21. Iannitti T., Rottigni V., Palmieri B. Apilot study to compare two different hyaluronic acid compounds for treatment of knee osteoarthritis. Int J Immunopathol Pharmacol 2012, 25:1093-1098.
22. Palmieri B., Rottigni V., Iannitti T. Preliminary study of highly cross-linked hyaluronic acid-based combination therapy for management of knee osteoarthritis-related pain. Drug Des Devel Ther 2013, 7:7-12.
23. Krishnan R., Caligaris M., Mauck R.L., Hung C.T., Costa K.D., Ateshian G.A. Removal of the superficial zone of bovine articular cartilage does not increase its frictional coefficient. Osteoarthritis Cartilage 2004, 12:947-955.
24. Jay G.D., Torres J.R., Warman M.L., Laderer M.C., Breuer K.S. The role of lubricin in the mechanical behavior of synovial fluid. Proc Natl Acad Sci U S A 2007, 104:6194-6199.
25. Gleghorn J.P., Jones A.R., Flannery C.R., Bonassar L.J. Boundary mode lubrication of articular cartilage by recombinant human lubricin. JOrthop Res 2009, 27:771-777.
26. Ludwig T.E., McAllister J.R., Lun V., Wiley J.P., Schmidt T.A. Diminished cartilage-lubricating ability of human osteoarthritic synovial fluid deficient in proteoglycan 4: restoration through proteoglycan 4 supplementation. Arthritis Rheum 2012, 64:3963-3971.
27. Seror J., Merkher Y., Kampf N., Collinson L., Day A.J., Maroudas A., et al. Articular cartilage proteoglycans as boundary lubricants: structure and frictional interaction of surface-attached hyaluronan and hyaluronan-aggrecan complexes. Biomacromolecules 2011, 12:3432-3443.
28. Roth A., Mollenhauer J., Wagner A., Fuhrmann R., Straub A., Venbrocks R.A., et al. Intra-articular injections of high-molecular-weight hyaluronic acid have biphasic effects on joint inflammation and destruction in rat antigen-induced arthritis. Arthritis Res Ther 2005, 7:R677-R686.
29. Kwiecinski J.J., Dorosz S.G., Ludwig T.E., Abubacker S., Cowman M.K., Schmidt T.A. The effect of molecular weight on hyaluronan's cartilage boundary lubricating ability-alone and in combination with proteoglycan 4. Osteoarthritis Cartilage 2011, 19:1356-1362.
30. Li P., Raitcheva D., Hawes M., Moran N., Yu X., Wang F., et al. Hylan G-F 20 maintains cartilage integrity and decreases osteophyte formation in osteoarthritis through both anabolic and anti-catabolic mechanisms. Osteoarthritis Cartilage 2012, 20:1336-1346.
31. Linn F.C., Radin E.L. Lubrication of animal joints. 3. The effect of certain chemical alterations of the cartilage and lubricant. Arthritis Rheum 1968, 11:674-682.
32. Walker P.S., Dowson D., Longfield M.D., Wright V. Lubrication of human joints. Ann Rheum Dis 1969, 28:194.